Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Conditions: Hereditary Hemorrhagic Telangiectasia; Arteriovenous Malformations; Telangiectasia; Epistaxis; GastroIntestinal Bleeding; Cerebral Arteriovenous Malformations; Vascular Malformation
Sponsors: Cure HHT; Augusta University; The Cleveland Clinic; Mayo Clinic; Massachusetts General Hospital; Columbia University; Oregon Health and Science University; University of California, Los Angeles; University of California, San Francisco; University of Colorado, Denver; University of North Carolina, Chapel Hill; University of Pennsylvania; University of Texas; University of Utah; Washington University School of Medicine; Yale University; Health Resources and Services Administration (HRSA)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 15, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments